Remedies for depression containing ep1 antagonist as the active ingredient
AssigneeOno Pharmaceutical Co., Ltd.
InventorsShigeyuki Nonaka, Takayuki Maruyama
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for the treatment and/or prevention of depression comprising a compound having an antagonistic activity for EP1 receptor which a prostaglandin E2 receptor subtype. EP1 antagonist is useful for the treatment of depression, for example, endogenous depression, reactive depression, weatherability depression, neurological depressed state, the depressed state of brain organic mental disorder.
Claims22
A pharmaceutical composition for the treatment and/or prevention of depression, which comprises the EP1 antagonist as active ingredient.
4-[5-trifluoromethyl-2-[N-(5-methy-2-furylcarbonyl)-N-isopropylamino]phenoxymethyl]cinnamic acid or a non-toxic salt thereof.
Dependencies are inferred from the claim text.